Manapad, Isnaira B.
HRN: 12-96-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
AMPICILLIN 250MG (VIAL)
04/20/2022
04/27/2022
IV
110MG
Q12H
PROM X 48 HRS
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines